A carregar...
PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives
More than simply a promising management option, PARP inhibitors can be regarded as a milestone in the development of personalised treatment of recurrent ovarian carcinoma. Their mechanism of action, known as “synthetic lethality”, is dependent on functional differences of the DNA repair mechanisms o...
Na minha lista:
| Publicado no: | Geburtshilfe Frauenheilkd |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Georg Thieme Verlag KG
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4771499/ https://ncbi.nlm.nih.gov/pubmed/26941449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1558185 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|